Mostrar el registro sencillo del ítem
Tumor programmed cell death ligand 1 expression correlates with nodal metastasis in patients with cutaneous squamous cell carcinoma of the head and neck
dc.contributor.author | García-Pedrero J.M. | |
dc.contributor.author | Martínez-Camblor P. | |
dc.contributor.author | Diaz-Coto S. | |
dc.contributor.author | Munguia-Calzada P. | |
dc.contributor.author | Vallina-Alvarez A. | |
dc.contributor.author | Vazquez-Lopez F. | |
dc.contributor.author | Rodrigo J.P. | |
dc.contributor.author | Santos-Juanes J. | |
dc.date.accessioned | 2020-09-02T22:18:51Z | |
dc.date.available | 2020-09-02T22:18:51Z | |
dc.date.issued | 2017 | |
dc.identifier | 10.1016/j.jaad.2017.05.047 | |
dc.identifier.citation | 77, 3, 527-533 | |
dc.identifier.issn | 01909622 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/4639 | |
dc.description | Background Binding of tumor-expressed programmed cell death ligand 1 (PD-L1) to the programmed cell death 1 (PD-1) surface receptor blocks T-cell activation thereby leading to immune evasion. Tumor PD-L1 expression has been associated with poor outcome in a wide variety of cancers; however, data in cutaneous squamous cell carcinoma (cSCC) are scarce and conflicting. Objective To investigate the relationship of tumor PD-L1 expression with the clinicopathologic features and prognosis of cSCC. Methods PD-L1 expression was analyzed by immunohistochemistry on paraffin-embedded tissue samples from 100 patients with cSCC. Cumulative/dynamic receiver operating characteristic curve was used to determine the optimal PD-L1 threshold. Kaplan-Meier estimators and Cox proportional hazards regression models were also used. Results On the basis of cumulative/dynamic receiver operating characteristic curves, we defined the cut-off score for PD-L1 expression as ≥25% of tumor cells positively stained. PD-L1 expression was a significant risk factor for nodal metastasis with crude and adjusted hazard ratios of 3.39 (1.71-6.65) and 6.54 (2.28-18.78), respectively. Limitations This is a retrospective study limited to cSCC of the head and neck. Conclusion These findings indicate that tumor PD-L1 expression predicts increased risk for nodal metastasis in patients with cSCC. © 2017 American Academy of Dermatology, Inc. | |
dc.language.iso | en | |
dc.publisher | Mosby Inc. | |
dc.subject | cutaneous squamous cell carcinoma | |
dc.subject | expression | |
dc.subject | immunohistochemistry | |
dc.subject | nodal metastasis | |
dc.subject | PD-L1 | |
dc.subject | prognosis | |
dc.subject | tumor | |
dc.subject | programmed death 1 ligand 1 | |
dc.subject | programmed death 1 ligand 1 | |
dc.subject | aged | |
dc.subject | Article | |
dc.subject | cancer patient | |
dc.subject | cancer prognosis | |
dc.subject | cancer staging | |
dc.subject | cancer survival | |
dc.subject | clinical feature | |
dc.subject | controlled study | |
dc.subject | female | |
dc.subject | follow up | |
dc.subject | head and neck carcinoma | |
dc.subject | histopathology | |
dc.subject | human | |
dc.subject | human tissue | |
dc.subject | immunohistochemistry | |
dc.subject | lymph node metastasis | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | overall survival | |
dc.subject | priority journal | |
dc.subject | protein expression | |
dc.subject | retrospective study | |
dc.subject | risk factor | |
dc.subject | skin carcinoma | |
dc.subject | T lymphocyte activation | |
dc.subject | tissue microarray | |
dc.subject | tumor differentiation | |
dc.subject | tumor growth | |
dc.subject | tumor volume | |
dc.subject | wide excision | |
dc.subject | biosynthesis | |
dc.subject | head and neck tumor | |
dc.subject | lymph node metastasis | |
dc.subject | metabolism | |
dc.subject | pathology | |
dc.subject | secondary | |
dc.subject | skin tumor | |
dc.subject | squamous cell carcinoma | |
dc.subject | very elderly | |
dc.subject | Aged | |
dc.subject | Aged, 80 and over | |
dc.subject | Antigens, CD274 | |
dc.subject | Carcinoma, Squamous Cell | |
dc.subject | Female | |
dc.subject | Head and Neck Neoplasms | |
dc.subject | Humans | |
dc.subject | Lymphatic Metastasis | |
dc.subject | Male | |
dc.subject | Retrospective Studies | |
dc.subject | Skin Neoplasms | |
dc.title | Tumor programmed cell death ligand 1 expression correlates with nodal metastasis in patients with cutaneous squamous cell carcinoma of the head and neck | |
dc.type | Article |